Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck.

por Inki, P., Joensuu, H., Grénman, R., Klemi, P., Jalkanen, M.
Publicado 1994

Syndecan-1 expression has prognostic significance in head and neck carcinoma

por Anttonen, A, Kajanti, M, Heikkilä, P, Jalkanen, M, Joensuu, H
Publicado 1999

Expression of Mad, an antagonist of Myc oncoprotein function, in differentiating keratinocytes during tumorigenesis of the skin.

por Lymboussaki, A., Kaipainen, A., Hatva, E., Västrik, I., Jeskanen, L., Jalkanen, M., Werner, S., Stenbäck, F., Alitalo, R.
Publicado 1996